Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Triamcinolone for Carpal Tunnel Syndrome
NCT04961281Completed
- Sponsor
- Assiut University
- Start
- Jul 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Assiut University. Primary endpoint: Pain Visual Analog Scale at 6 months. Started Jul 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT04961281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04961281.